Putting Our Heads Together
Posted in News on Apr 1st, 2009
Medical experts Tuesday said positive responses in patients taking Genentech Inc.’s Avastin were sufficient to support approving the drug to treat an aggressive form of brain cancer that affects 10,000 people annually.
Posted in News on Apr 1st, 2009
Advisers to the Food and Drug Administration unanimously recommended Tuesday that Genentech’s drug Avastin be approved as a treatment for a deadly form of brain cancer, despite the F.D.A.’s own staff reviewers’ saying there was a lack of compelling evidence that the drug worked for that use.
